Recruiting
NA
INTERVENTIONAL
NCT06914583
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The aim of the study is to evaluate the safety and efficacy of sodium hyaluronate 32 mg/ml in improving facial skin dryness and dullness. Subjects are randomized to the treatment group or to the control group. Only subjects in the treatment group are treated by intradermal injection.
Detailed Description
This is a prospective multi-center clinical investigation. Enrolled subjects are randomized to the treatment group or to the no-treatment control group. The treatment group will receive intradermal injections of sodium hyaluronate 32 mg/ml. The improvement of facial skin dryness and dullness will be evaluated at multiple timepoints.
Interventions
Name:
Sodium Hyaluronate
Type:
DEVICE
Description:
Sodium Hyaluronate 32 mg/ml
Primary Outcomes
Measure:
GAIS (Global Aesthetic Improvement Scale) - Blinded evaluator
TimeFrame:
12 week
Description:
Treatment effective rate (third-party blinded investigator assessment)
Trial Information
NCT ID
NCT06914583
Status
Recruiting
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
IBSA Farmaceutici Italia Srl
Last Updated
December 15, 2025